Colorectal cancer
368 results
1 - 100
Antioxidants don't prevent colorectal cancer- Symptoms not reliable in diagnosing colorectal cancer
- Aspirin = screening to prevent colorectal cancer mortality
- Colorectal cancer risk is increased in first-degree relatives
- USPSTF 2016: updated recommendations for colorectal cancer screening
- SR: BRCA mutations are not associated with colorectal cancer
- Flex sig reduces incidence and mortality of colorectal cancer
- Fecal immunochemical testing accurate for colorectal cancer screening
- American Gastroenterological Association position statements for colorectal cancer screening
- Nonadvanced colon adenoma may not increase colorectal cancer risk
- Accuracy of fecal DNA and fecal immunochemical test for colorectal cancer detection
- Colorectal cancer screening modalities: variable uptake, variable yield (SAVE)
- USPSTF: Some adults should take aspirin to prevent CVD, colorectal cancer
- No increased survival benefit to intensive follow-up after colorectal cancer surgery
- Invitation to a single colonoscopy has only modest impact on colorectal cancer incidence (NordICC)
- Every-other-year FIT is at least as effective as a single sigmoidoscopy to detect colorectal cancer
- High adenoma detection rate during colonoscopy associated with lower incidence of colorectal cancer
- Long-term follow-up of CAPP2: aspirin prevents colorectal cancer in Lynch syndrome carriers
- FIT more acceptable with better detection rate than gFOBT for colorectal cancer screening
- Mailing FIT or gFOBT directly to patients increases uptake of colorectal cancer screening
- Exercise plus behavioral support significantly increases overall survival in patients with colorectal cancer (CHALLENGE)
- Additional evidence of no increased survival benefit to intensive follow-up after colorectal cancer surgery
- Network meta-analysis: Limited data show that high-dose aspirin decreases incidence of colorectal cancer
- Results of fecal immunochemical tests for colorectal cancer screening not affected by NSAIDs, aspirin, or anticoagulants
- FIT has similar yield as colonoscopy for colorectal cancer and advanced adenoma over 10 years
- Consider not screening average-risk adults aged 45-49 years for colorectal cancer; stick to usual means of screening
- DNA-based blood test: 82% sensitive and 91% specific for colorectal cancer, but only 12% sensitive for advanced adenoma
- Cell-free DNA blood test 83% sensitive for colorectal cancer, 13% sensitive for advanced adenoma; mortality data lacking (ECLIPSE)
- Colonoscopy more than 10 months after positive FIT increases risk of colorectal cancer and more advanced-stage disease